TY - JOUR
T1 - Three-color flow cytometric study on lymphocytes derived from thymic diseases
AU - Okumura, Meinoshin
AU - Fujii, Yoshitaka
AU - Miyoshi, Shinichiro
AU - Shiono, Hiroyuki
AU - Inoue, Masayoshi
AU - Kadota, Yoshihisa
AU - Fukuhara, Kenjirou
AU - Matsuda, Hikaru
N1 - Funding Information:
This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture. We are grateful to Dr. Takashi Mori, Dr. Keiji Iuchi (National Kinki Central Hospital for Chest Diseases), Dr. Tsutomu Yasumitsu, Dr. Yahiro Kotake (Osaka Prefectural Habikino Hospital), Dr. Osamu Kuwa-hara, Dr. Hajime Maeda (National Toneyama Hospital), Dr. Kazuya Nakahara, Dr. Akihide Matsumura (Ohtemae Hospital), Dr. Sogo Iioka, Dr. Hiroto Tada (Osaka City General Hospital), Dr. Wataru Kamiike, Dr. Hyung-Eng Yoon, Dr. Yasushi Tanaka (Rinku Medical Center), Dr. Kenji Nakamura (National Kure Hospital), Dr. Tetsuo Kido (Osaka Prefectural Hospital), and Dr. Akinori Akashi (Takara-zuka City Hospital) for submission of the specimens. We are also grateful to Reiko Tsubouchi and Chika Ariga for technical support and to Naoko Araki for secretarial work.
PY - 2001
Y1 - 2001
N2 - Background. Anterior mediastinal masses derive from a variety of diseases. Thymomas have been shown to commonly hold CD4+CD8+ double-positive (DP) lymphocytes, and identification of this subset by two-color flow cytometric study was suggested to help diagnosis of thymoma. Several other thymic diseases, however, possibly hold CD4+CD8+ DP lymphocytes. In this study, we utilized the three-color flow cytometric method for further examination of the phenotypes of lymphocytes in the thymic diseases. Materials and methods. One hundred eight specimens (77 primary and 10 metastatic thymomas, 10 thymic carcinomas, 2 thymic carcinoids, 4 malignant lymphomas, 2 seminomas, an inflammatory pseudotumor, and 2 nonneoplastic thymic hyperplasias) were subjected to the study. The expressions of CD3, CD4, and CD8 on tumor-associated lymphocytes were evaluated by three-color flow cytometric study. Results. The proportion of the CD4+CD8+ DP subset was more than 30% in all 78 lymphocyte-rich thymomas, in 2 malignant lymphomas, and in both thymic hyperplasias. CD3 expression of the CD4+CD8+ DP subset ranged from a negative to a high level in thymomas and thymic hyperplasias, while it was restricted to a particular level in CD4+CD8+ DP-type malignant lymphomas. The proportion of CD3+ cells in the CD4+CD8- single-positive subset was consistently less than 90% in the lymphocyte-rich thymomas, while it was more than 90% in the thymic hyperplasias. Conclusion. Although identification of the CD4+CD8+ DP subset in the tumor-associated lymphocytes does not necessarily indicate thymoma, a further characterization of thymic neoplasms possessing the CD4+CD8+ DP subset was enabled by three-color flow cytometric study, suggesting the utility of this method as an anciliary tool for differential diagnosis of these diseases.
AB - Background. Anterior mediastinal masses derive from a variety of diseases. Thymomas have been shown to commonly hold CD4+CD8+ double-positive (DP) lymphocytes, and identification of this subset by two-color flow cytometric study was suggested to help diagnosis of thymoma. Several other thymic diseases, however, possibly hold CD4+CD8+ DP lymphocytes. In this study, we utilized the three-color flow cytometric method for further examination of the phenotypes of lymphocytes in the thymic diseases. Materials and methods. One hundred eight specimens (77 primary and 10 metastatic thymomas, 10 thymic carcinomas, 2 thymic carcinoids, 4 malignant lymphomas, 2 seminomas, an inflammatory pseudotumor, and 2 nonneoplastic thymic hyperplasias) were subjected to the study. The expressions of CD3, CD4, and CD8 on tumor-associated lymphocytes were evaluated by three-color flow cytometric study. Results. The proportion of the CD4+CD8+ DP subset was more than 30% in all 78 lymphocyte-rich thymomas, in 2 malignant lymphomas, and in both thymic hyperplasias. CD3 expression of the CD4+CD8+ DP subset ranged from a negative to a high level in thymomas and thymic hyperplasias, while it was restricted to a particular level in CD4+CD8+ DP-type malignant lymphomas. The proportion of CD3+ cells in the CD4+CD8- single-positive subset was consistently less than 90% in the lymphocyte-rich thymomas, while it was more than 90% in the thymic hyperplasias. Conclusion. Although identification of the CD4+CD8+ DP subset in the tumor-associated lymphocytes does not necessarily indicate thymoma, a further characterization of thymic neoplasms possessing the CD4+CD8+ DP subset was enabled by three-color flow cytometric study, suggesting the utility of this method as an anciliary tool for differential diagnosis of these diseases.
KW - Malignant lymphoma
KW - Thymic carcinoma
KW - Thymic hyperplasia
KW - Thymoma
UR - http://www.scopus.com/inward/record.url?scp=0035674763&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035674763&partnerID=8YFLogxK
U2 - 10.1006/jsre.2001.6282
DO - 10.1006/jsre.2001.6282
M3 - Article
C2 - 11735267
AN - SCOPUS:0035674763
SN - 0022-4804
VL - 101
SP - 130
EP - 137
JO - Journal of Surgical Research
JF - Journal of Surgical Research
IS - 2
ER -